Abstract:A tumor-targeting fluorescent probe has attracted increasing interest in fluorescent imaging for the noninvasive detection of cancers in recent years. Sulfonamide-containing naphthalimide derivatives (SN-2NI, SD-NI) were synthesized by the incorporation of N-butyl-4-ethyldiamino-1,8-naphthalene imide (NI) into sulfonamide (SN) and sulfadiazine (SD) as the tumor-targeting groups, respectively. These derivatives were further characterized by mass spectrometry (MS), nuclear magnetic resonance spectroscopy (1H NMR), Fourier transform infrared spectroscopy (FT-IR), ultraviolet–visible spectroscopy (UV), and a fluorescence assay. In vitro properties, including cell cytotoxicity and the cell uptake of tumor cells, were also evaluated. Sulfonamide-containing naphthalimide derivatives possessed low cell cytotoxicity to B16F10 melanoma cells. Moreover, SN-2NI and SD-NI can be taken up highly by B16F10 cells and then achieve good green fluorescent images in B16F10 cells. Therefore, sulfonamide-containing naphthalimide derivatives can be considered to be the potential probes used to target fluorescent imaging in tumors.

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of a tumor-targeting fluorescent probe for non-invasive cancer detection. Specifically, the researchers synthesized naphthalimide derivatives containing sulfonamide groups (SN-2NI and SD-NI), which can be efficiently taken up by tumor cells and produce good green fluorescent images within them. Through this fluorescent probe, highly sensitive imaging of tumor cells can be achieved, and imaging contrast can be improved. ### Main Issues: 1. **Development of Tumor-Targeting Fluorescent Probes**: Existing low-molecular-weight fluorescent probes are often rapidly excreted from the body and lack tumor-targeting properties, limiting their application in tumor imaging. Therefore, there is a need to develop fluorescent probes with tumor-targeting capabilities to improve the signal-to-noise ratio of imaging and the acquisition of quantitative, spatiotemporal index information. 2. **Improving Imaging Contrast and Sensitivity**: By introducing sulfonamide groups (SN) and sulfadiazine groups (SD) into naphthalimide (NI) fluorescent molecules, new fluorescent probes are synthesized. These probes can efficiently accumulate in tumor cells, thereby improving imaging contrast and sensitivity. ### Solution: - **Synthesis of Naphthalimide Derivatives Containing Sulfonamide Groups**: Through chemical synthesis methods, sulfonamide groups (SN) and sulfadiazine groups (SD) are introduced into naphthalimide (NI) fluorescent molecules to prepare two fluorescent probes, SN-2NI and SD-NI. - **Characterization and Evaluation of Probe Properties**: The synthesized fluorescent probes are characterized using mass spectrometry (MS), nuclear magnetic resonance (1H NMR), Fourier-transform infrared spectroscopy (FT-IR), ultraviolet-visible spectroscopy (UV), and fluorescence analysis. Additionally, cytotoxicity tests and cellular uptake experiments are conducted to evaluate their performance in vitro. - **Validation of Fluorescent Imaging Effects**: Fluorescent imaging experiments validate the fluorescent imaging effects of SN-2NI and SD-NI in B16F10 melanoma cells. The results show that these probes can be efficiently taken up by the cells and produce good green fluorescent images. In summary, this paper aims to develop tumor-targeting fluorescent probes by synthesizing and characterizing naphthalimide derivatives containing sulfonamide groups, thereby improving the contrast and sensitivity of tumor imaging.

Synthesis and Characterization of Sulfonamide-Containing Naphthalimides as Fluorescent Probes

A novel highly sensitive fluorescent probe for bioimaging biothiols and its applications in distinguishing cancer cells from normal cells.

Naphthalimide‐based Functional Glycopolymeric Nanoparticles as Fluorescent Probes for Selective Imaging of Tumor Cells

Fluorescent naphthalimide boronates as theranostics: structural investigations, confocal fluorescence and multiphoton fluorescence lifetime imaging microscopy in living cells

Sulfamide-substituted-BODIPY Based Fluorescence Drugs: Synthesis, Spectral Characteristics, Molecular Docking, and Bioactivity

Novel Benzo-Bis(1,2,5-thiadiazole) Fluorophores for in Vivo NIR-II Imaging of Cancer

Research Progress on Naphthalimide Fluorescent Probes

A Near-Infrared Multifunctional Fluorescent Probe With An Inherent Tumor-Targeting Property For Bioimaging

A Novel BODIPY Quaternary Ammonium Salt-Based Fluorescent Probe: Synthesis, Physical Properties, and Live-Cell Imaging

Discovery of novel tumor-targeted near-infrared probes with 6-substituted pyrrolo[2,3- d ]pyrimidines as targeting ligands

Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging

Synthesis of a Novel IR-822-Met Near-Infrared Probe for in Vivo Tumor Diagnosis

Design and Synthesis of Fluorescent 1,8-Napthalimide Derivatives and Their Identification of Cysteine

Symmetry dual functional pyrimidine-BODIPY probes for imaging targeting and activity study

Fluorescent and Theranostic Probes for Imaging Nicotinamide Phosphoribosyl Transferase (NAMPT).

An NIR Fluorescent/photoacoustic Dual-Mode Probe of NADPH for Tumor Imaging

Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z ) for Near Infrared Fluorescence Imaging of Cancer

Design and Synthesis of Novel Near-Infrared Fluorescence Probes Based on an Open Conformation of a Cytochrome P450 1B1 Complex for Molecular Imaging of Colorectal Tumors.

In Vivo Cancer Targeting and Fluorescence-Ct Dual-Mode Imaging with Nanoprobes Based on Silver Sulfide Quantum Dots and Iodinated Oil

Fluorescence properties and antiproliferative effects of mono-, bis-, and tris- thiophenylnaphthalimides: results of a comparative pilot study.

Smart On-Site Immobilizable Near-Infrared II Fluorescent Nanoprobes for Ultra-Long-Term Imaging-Guided Tumor Surgery and Photothermal Therapy